Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study.
Aleksandar Sekulic
No relevant relationships to disclose
Michael R. Migden
Honoraria - Genentech
Research Funding - Genentech
Other Remuneration - Genentech
Nicole Basset-Seguin
Consultant or Advisory Role - Roche
Honoraria - Roche
Claus Garbe
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Philogen; Roche; SOBI
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Philogen; Roche; SOBI
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Roche; SOBI
Anja Gesierich
Honoraria - Roche
Other Remuneration - Roche
Christopher D. Lao
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Chris Miller
No relevant relationships to disclose
Laurent Mortier
Consultant or Advisory Role - Genentech
Dedee F. Murrell
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Omid Hamid
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
Fernando Quevedo
No relevant relationships to disclose
Dirk Schadendorf
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Research Funding - Merck
Jeannie Hou
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Huibin Yue
Employment or Leadership Position - Roche
Stock Ownership - Roche